tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Hoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
PremiumThe FlyHoth Therapeutics’ HT-001 shows 100% response in EFGR-treated cancer patients
2M ago
Hoth Therapeutics receives approval for HT-KIT cancer program patent in China
Premium
The Fly
Hoth Therapeutics receives approval for HT-KIT cancer program patent in China
2M ago
Hoth Therapeutics highlights obesity and pipeline progress to regulators
Premium
Company Announcements
Hoth Therapeutics highlights obesity and pipeline progress to regulators
2M ago
Hoth Therapeutics Prepares Presentation on October 17, 2025
PremiumCompany AnnouncementsHoth Therapeutics Prepares Presentation on October 17, 2025
5M ago
AI Daily: Nvidia CEO ‘surprised’ AMD offered 10% stake in OpenAI deal
Premium
The Fly
AI Daily: Nvidia CEO ‘surprised’ AMD offered 10% stake in OpenAI deal
5M ago
Hoth Therapeutics selects Nvidia AI enterprise platform
Premium
The Fly
Hoth Therapeutics selects Nvidia AI enterprise platform
5M ago
Hoth Therapeutics Renews CEO Contract Amidst Patent Filing
PremiumCompany AnnouncementsHoth Therapeutics Renews CEO Contract Amidst Patent Filing
7M ago
Hoth Therapeutics Holds Annual Shareholder Meeting
Premium
Company Announcements
Hoth Therapeutics Holds Annual Shareholder Meeting
8M ago
Hoth Therapeutics extending Phase II trial of HT-001 in cancer patients to EU
Premium
The Fly
Hoth Therapeutics extending Phase II trial of HT-001 in cancer patients to EU
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100